Natures Sunshine Products

NATRNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$232.613 M

$13.22 +1.54%

Close of 22 Sept 2026

Revenue

$480.1M

#1928 by revenue

Earnings

$19.5M

#1878 by earnings

Shares outstanding

17,595,520

Latest filing cover page

P/E ratio

11.9

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#255Eledon PharmaceuticalsELDN$234.8M
#256Siga TechnologiesSIGA$234.2M
#257Natures Sunshine ProductsNATR$232.6M
#258Keros TherapeuticsKROS$232.6M
#259Whitehawk TherapeuticsWHWK$230.3M

Insiders buying

All insider buying →

2 open-market purchases by officers and directors of Natures Sunshine Products, worth $2.61M. Grants and option exercises are excluded.

Phil Frohlich, PRESCOTT GROUP AGGRESSIVE SMALL CAP II LP, PRESCOTT GROUP AGGRESSIVE SMALL CAP LP, PRESCOTT GROUP AGGRESSIVE SMALL CAP MASTER FUND GP, PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.$293.8K
20,000 shares at $14.69 on 17 Aug 2026 · filed 19 Aug 2026
Phil Frohlich, PRESCOTT GROUP AGGRESSIVE SMALL CAP II LP, PRESCOTT GROUP AGGRESSIVE SMALL CAP LP, PRESCOTT GROUP AGGRESSIVE SMALL CAP MASTER FUND GP, PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.$2.32M
141,389 shares at $16.40 on 6 Aug 2026 · filed 10 Aug 2026

What if Natures Sunshine Products were worth as much as…

Open the what-if tool →

Gold $30.2T

$1,718,277

Per share 129,976× higher

Bitcoin $1.74T

$98,982.87

Per share 7,487× higher

Nvidia $5.52T

$313,475.65

Per share 23,712× higher

Or at a round number

$500.0M $1.00B $2.00B $5.00B

Where these numbers come from

Share counts and financials for Natures Sunshine Products are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.